These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24816974)

  • 1. The protective arms of the renin-angiontensin system in stroke.
    McCarthy CA; Facey LJ; Widdop RE
    Curr Hypertens Rep; 2014 Jul; 16(7):440. PubMed ID: 24816974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does blockade of angiotensin II receptors offer clinical benefits over inhibition of angiotensin-converting enzyme?
    de Gasparo M; Levens N
    Pharmacol Toxicol; 1998 Jun; 82(6):257-71. PubMed ID: 9677617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Hypertens Suppl; 1997 Dec; 15(6):S31-6. PubMed ID: 9493125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preclinical basis of the therapeutic evaluation of losartan.
    Timmermans PB; Wong PC; Chiu AT; Smith RD
    J Hypertens Suppl; 1995 Jul; 13(1):S1-13. PubMed ID: 18800450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure lowering and renin-angiotensin system blockade.
    Unger T
    J Hypertens Suppl; 2003 Jul; 21(6):S3-7. PubMed ID: 14513945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
    Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting renin-angiotensin in the brain: the possible therapeutic implications.
    Unger T
    Blood Press Suppl; 2001; 1():12-6. PubMed ID: 11333008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of RAAS inhibition on stroke prevention].
    Tanahashi N
    Nihon Rinsho; 2012 Sep; 70(9):1582-7. PubMed ID: 23012807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal and cardio-protective effects of direct renin inhibition: a systematic literature review.
    Lambers Heerspink HJ; Perkovic V; de Zeeuw D
    J Hypertens; 2009 Dec; 27(12):2321-31. PubMed ID: 19727007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection.
    Lambers Heerspink HJ
    Contrib Nephrol; 2013; 179():7-14. PubMed ID: 23652444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of renin inhibition in treating the hypertensive patient with diabetes: a summary of preclinical and clinical evidence.
    Abdellatif AA
    Expert Rev Cardiovasc Ther; 2012 Feb; 10(2):251-63. PubMed ID: 22292880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis.
    Ye R; Hu Y; Yao A; Yang Y; Shi Y; Jiang Y; Zhang J
    Int J Clin Pract; 2015 Jun; 69(6):674-81. PubMed ID: 25721930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are angiotensin receptor blockers neuroprotective?
    Thöne-Reineke C; Zimmermann M; Neumann C; Krikov M; Li J; Gerova N; Unger T
    Curr Hypertens Rep; 2004 Aug; 6(4):257-66. PubMed ID: 15257859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of angiotensin receptor blockers in cerebrovascular disorders and dementia: bonus in addition to the antihypertensive effect].
    Kovács T
    Ideggyogy Sz; 2014 May; 67(5-6):149-68. PubMed ID: 25087375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blockade of renin-angiotensin-aldosterone system in hemodialysis patients to control hypertension and prevent cardiovascular disease: optimal pharmacotherapy.
    Morishita Y; Kusano E
    Cardiovasc Hematol Agents Med Chem; 2011 Oct; 9(4):241-6. PubMed ID: 22023537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin inhibition--benefit beyond hypertension control.
    Kher V
    J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection in Stroke-Focus on the Renin-Angiotensin System: A Systematic Review.
    Andone S; Bajko Z; Motataianu A; Maier S; Barcutean L; Balasa R
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.